Ratings H.U. Group Holdings, Inc.

Equities

4544

JP3822000000

Delayed Japan Exchange Other stock markets 22:30:00 2024-04-30 EDT			5-day change	1st Jan Change
2,293 ^JPY	-4.56%		-4.34%	-13.91%

04-26	H.U. Group Holdings, Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	CI
04-26	H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Executive Officer	CI

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company appears to be poorly valued given its net asset value.
This company will be of major interest to investors in search of a high dividend stock.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's earnings growth outlook lacks momentum and is a weakness.
The company does not generate enough profits, which is an alarming weak point.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 362.35 times its estimated earnings per share for the ongoing year.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Most analysts recommend that the stock should be sold or reduced.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	ESG Refinitiv
H.U. GROUP HOLDINGS, INC.	-13.91%	876M	A-
SONIC HEALTHCARE LIMITED	-17.52%	8.43B	B+
RADNET, INC.	+39.49%	3.62B	C+
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-38.71%	2.61B	B-
SYNLAB AG	-8.06%	2.48B	-
DR. LAL PATHLABS LIMITED	-7.96%	2.34B	B-
NEOGENOMICS, INC.	-13.97%	1.94B	C-
FLEURY S.A.	-19.73%	1.56B	A-
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.78%	1.26B	C+
METROPOLIS HEALTHCARE LIMITED	+8.32%	1.1B	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes